Sulkowska M, Sulkowski S, Skrzydlewska E, Farbiszewski R
Department of Pathological Anatomy, University Medical School of Białystok, Poland.
Exp Toxicol Pathol. 1998 Jun;50(3):209-20. doi: 10.1016/S0940-2993(98)80085-7.
Cyclophosphamide (CP) causes lung toxicity in animals and humans. The mechanisms of pulmonary damage caused by CP are not fully understood. Possibilities include direct toxicity to pulmonary tissue or indirect toxicity through activation of pulmonary inflammatory cells. The aim of the present study was the ultrastructural analysis (in transmission electron microscope) of the changes following CP administration within the structures forming the interalveolar septum of the lungs, particularly type II epithelial cells. An attempt was also made to reveal a correlation between the morphological changes, intensity of lipid peroxidation in lung tissue homogenates and blood serum collected from the left ventricle of the heart and the alterations in the activities of superoxide dismutase (Cu, Zn-SOD) and glutathione reductase (GSSG-R). The experiment used 40 male Wistar rats of 160-180 g body weight (b.w.). The animals were divided into two groups. Group I - (20 animals) were given single intraperitoneal (i.p.) dose of 150 mg CP/1 kg b.w./1 ml PBS. Group II - (20 animals) were given single i.p. dose of 1 ml PBS. All experimental animals were sacrificed after 1 (subgroups I, II-1) and 7 (subgroups I, II-7) days of CP (or PBS) treatment. I.p. administration of CP caused an increase in lipid peroxidation products (MDA-malondialdehyde) in lung tissue homogenates especially in subgroup I-1 (p = 0.00174). No statistical differences, however, were noted in the blood serum MDA levels, although a statistically significant decrease was found in GSSG-R (p = 0.00174) and SOD (p = 0.00174) activities in the serum. The paper discusses a potential link between the findings of biochemical analysis and the morphological changes found within lung tissue. Pulmonary trombopoesis was indicated as a possible mechanism preventing a decrease in blood platelet count following CP administration.
环磷酰胺(CP)可导致动物和人类出现肺毒性。CP所致肺损伤的机制尚未完全明确。可能的机制包括对肺组织的直接毒性作用或通过激活肺炎症细胞产生的间接毒性作用。本研究的目的是利用透射电子显微镜对CP给药后肺内形成肺泡间隔的结构,尤其是II型上皮细胞的变化进行超微结构分析。同时还尝试揭示形态学变化、肺组织匀浆及从心脏左心室采集的血清中脂质过氧化强度与超氧化物歧化酶(铜锌超氧化物歧化酶)和谷胱甘肽还原酶活性改变之间的相关性。实验使用了40只体重为160 - 180克的雄性Wistar大鼠。动物被分为两组。第一组(20只动物)腹腔注射150毫克CP/1千克体重/1毫升磷酸盐缓冲液(PBS)。第二组(20只动物)腹腔注射1毫升PBS。所有实验动物在CP(或PBS)治疗1天(第一组、第二组-1亚组)和7天(第一组、第二组-7亚组)后处死。腹腔注射CP导致肺组织匀浆中脂质过氧化产物(丙二醛)增加,尤其是在第一组-1亚组(p = 0.00174)。然而,血清丙二醛水平未发现统计学差异,尽管血清中谷胱甘肽还原酶(p = 0.00174)和超氧化物歧化酶(p = 0.00174)活性出现了统计学显著下降。本文讨论了生化分析结果与肺组织内形态学变化之间的潜在联系。肺血小板生成被认为是CP给药后防止血小板计数下降的一种可能机制。